How can the food industry innovate for GLP-1 drug users?
The use of GLP-1 drugs for weight loss has surged.In January, the market value of Novo Nordisk, the Danish pharmaceutical giant behind leading GLP-1 drug brands Wegovy and Ozempic, reached 500 billion USD, after the company reported sales of its obesity care products had increased by 154% in 2020. The category of pharmaceuticals now makes